A landmark study presented at the 2025 European Society for Medical Oncology (ESMO) Congress by The University of Texas MD Anderson Cancer Center has provided compelling new evidence that mRNA technology may play a far greater therapeutic role than previously understood. While mRNA platforms gained global attention for their rapid...